Form 4: Arteris VP Exercises Options, Sells Shares

Arteris VP and General Counsel Paul Alpern exercised options and subsequently sold an equal number of common shares under a pre-arranged 10b5-1 trading plan.

Summary

• Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), engaged in a transaction on September 15, 2025, involving the company's common stock.
• Alpern acquired 10,000 shares of common stock by exercising derivative securities (options) at a price of $0.56 per share.
• On the same day, Alpern sold 10,000 shares of common stock at a weighted average price of $8.8805 per share, with individual sales ranging from $8.73 to $8.97.
• Both the acquisition and disposition transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on June 5, 2025.
• Following these transactions, Alpern beneficially owns 73,587 shares of common stock directly and 90,000 derivative securities (options) directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (exercise and sell-to-cover/liquidity) executed under a pre-arranged 10b5-1 plan, which typically carries a neutral sentiment as it is not indicative of new material information or a change in company fundamentals.

Positives

• The exercise price of $0.56 per share for the options is significantly lower than the sale price of $8.8805 per share, indicating a profitable transaction for the insider.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned and systematic approach to managing equity holdings rather than a reaction to recent non-public information.

Negatives

• The sale of common stock by a Vice President and General Counsel, even under a 10b5-1 plan, represents a reduction in direct insider ownership, which some investors may interpret as a lack of confidence, though this is often a routine liquidity event.

Stakeholder Impact

• Shareholders: The transaction represents a minor reduction in direct insider ownership, which is generally a routine event for liquidity or diversification purposes, especially when executed under a 10b5-1 plan. It is unlikely to have a significant impact on shareholder sentiment or company valuation.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the exercise of options and subsequent sale of shares under a pre-established 10b5-1 trading plan. Such transactions are typically for personal financial planning or liquidity and do not usually signal a change in the company's fundamental outlook or performance. Therefore, this specific filing alone does not warrant a change in investment recommendation, and a 'hold' stance remains appropriate based solely on this information.

Keywords

Arteris, AIP, Insider Transaction, Form 4, Stock Options, 10b5-1 Plan, Paul Alpern, Equity Sale